Preclinical Development

To advance new drug candidates into clinical trials, a high-quality preclinical development program that meets FDA regulatory guidelines and is managed by a team you trust is of paramount importance. IITRI’s experienced study directors work collaboratively with you to design a customized preclinical testing program that is tailored to the characteristics of your drug candidate and your timeline, and follows regulatory guidelines.

As a preclinical CRO, IITRI offers all functions of drug development studies at one location, including toxicology, pathology, and bioanalytical, for seamless management of your IND-enabling studies and programs.

We also partner with other organizations to extend our capabilities or give recommendations for other CDMOs or CROs if we cannot meet your study needs. One key collaboration is with a veterinary consulting group for advanced surgical and disease models, to better support preclinical toxicology, drug, and device development studies.